Table 1.
Age and sex distribution across groups.
Table 2.
Reactogenicity within 7 days after first vaccination in children aged 3–17 years: number and proportion subjects per age and vaccine group experiencing each solicited reaction at least once during period Day 0–7.
Table 3.
Reactogenicity within 7 days after first vaccination in children aged 6–35 months: number and proportion subjects per age and vaccine group experiencing each solicited reaction at least once during period Day 0–7.
Figure 1.
Haemagglutination inhibition antibody response 21 days after two injections, 21 days apart of adjuvanted or non-adjuvanted H5N1 vaccine.
Results are presented per age and vaccine formulation group as geometric mean titres (GMT) and the proportion of subjects with titres ≥32.
Table 4.
Neutralising antibody response 21 days after one and two injections, 21 days apart of adjuvanted or non-adjuvanted H5N1 vaccine.
Figure 2.
Levels of IFNγ and IL5 secreted after in vitro re-stimulation with recombinant H5 haemagglutinin by cells obtained before and eight days after two injections, 21 days apart, of adjuvanted or non-adjuvanted H5N1 vaccine in groups of children aged 6–35 months.
Symbols represent results from individual samples, bars indicate the median level.